WP1 has been set the objective of providing the Alliance with an overall scientific and governance structure that will facilitate collaboration, support, and effective supervision among all our partners. Such a clear statement of goals and expected outcomes will ensure the quality and timeliness of deliverables and that the project’s objectives are effectively managed.
Objectives
- Coordinating all activities, logistics, and tracking and reporting progress;
- Approving the project’s deliverables and the processes they involve;
- Ensuring that mechanisms are put in place for overall contractual, financial, ethical, administrative management, and to resolve conflicts;
- Creating and organizing internal communication channels and tools for disseminating information about successful results (together with WP7);
- Aligning all aspects of the project to ensure that all stakeholders and partners are fully engaged;
- Identifying short-term and long-term sustainability strategies.
Work Package Partners
AEMPS, Amgen, AP-HP, Barts Health, Bayer, BfArM, Celgene, EAPM, EBMT, EHA, ELN, EORTC, Erasmus MC, ERIC, FisM Onlus, GFM, GMV, Goethe University, GPOH, GRAALL, GRL-SANGER, HHU, Hospital La Fe, IECSCYL-IBSAL, IJC, Janssen, LeukaNET, LMU, LYSA, MediSapiens, MediUni Wien, Menarini, MML, MU, Newcastle University, NICE, Novartis, OPBG, SYNAPSE, Takeda, UCAM, Ulm University, UNIBO, UNITO, University of Helsinki, University of Navarra, University of Rome Tor Vergata, University of York, VHIO, VIB, VUMC.
Work Package Leadership
“HARMONY is a Network of Excellence in Hematology that goes beyond scientific collaboration to integrate the efforts of all Healthcare System Stakeholders. Ultimately, HARMONY aims to facilitate the access to the right treatment for the right patient at the right time.”
Jesús María Hernández Rivas, Research group in Molecular Cytogenetics, IBSAL
HARMONY Coordinator
“HARMONY Alliance is the largest European public-private partnership initiative aiming to improve the outcomes of patients with Hematological Malignancies through the use of big data sharing among all relevant stakeholders involved.”
Guillermo Sanz , Head of Clinical Hematology Section, Fundación para la Investigación del Hospital Universitario La Fe de la Comunidad Valenciana (HULAFE)
HARMONY Co-Chair
“HARMONY is boldly addressing the collective action problem related to the use of health data for research and care provision – in one single go. Public and private partners have really come together to share, integrate and analyse clinical, genomic and real-world data to improve the health outcomes of cancer patients and address the challenges that cancer care faces.”
Frederico Calado, Global Head RWE Innovation & Partnerships, Novartis Oncology
HARMONY Lead
” “HARMONY is one of the major initiatives in Europe focused on patient unmet need in Haematology. It is a critical collaborative effort between public and private stakeholders using the most advanced Big Data platform. HARMONY will contribute to innovation for patients, through this major collaboration in Europe, with clinicians, patients, cooperative group, regulatory authorities, HTA bodies and the pharmaceutical industry.””
Yann Guillevic, External Collaborations & Partnership Lead, Celgene, a Bristol Myers Squibb company
HARMONY Co-Lead